About MS Bioworks
MS Bioworks is a Healthcare company based in Detroit (United States) founded in 2010 by Ravi Amunugama, Richard Jones, Michael Ford, and David Allen. It provides proteomics analysis, protein profiling, and modification services for scientific research. It operates on a B2B model. Its website msbioworks.com draws about 10 thousand monthly visits. MS Bioworks offers products and services including Reactive Cysteine Profiling, MHC Immunopeptidomics, High Resolution Spatial Proteomics, Quantitative Proteomics Services, and Post-Translational Modification Analysis. Its focus areas include Biotechnology, Proteomics, Mass Spectrometry Services and Life Sciences. Similar companies include Nautilus Biotechnology, ProteinSimple and Somalogic; 3 of its 3 listed similar companies have raised funding.
Company details
MS Bioworks delivers advanced proteomics services using mass spectrometry to analyze proteins and their modifications. Based in Ann Arbor, Michigan, USA, the company serves over 2,000 global customers with offerings like reactive cysteine profiling, immunopeptidomics, and quantitative proteomics. They handle projects from routine protein identification to custom assays, ensuring high-quality results for research in healthcare and biotechnology.
- Headquarters Detroit, United States
- Founders Ravi Amunugama, Richard Jones, Michael Ford, David Allen
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website msbioworks.com
- Social X
Products & Services of MS Bioworks
MS Bioworks offers a comprehensive portfolio of products and services, including Reactive Cysteine Profiling, MHC Immunopeptidomics, High Resolution Spatial Proteomics, Quantitative Proteomics Services, and Post-Translational Modification Analysis.
Identifies drug binding sites and off-target effects via mass spectrometry.
Analyzes antigenic peptides for disease and immune research.
Maps protein constituents in tissues for advanced discovery.
Studies protein dynamics in cells and organisms accurately.
Identifies and quantifies modifications on proteins globally.
People of MS Bioworks
4 people are tracked at MS Bioworks (4 in leadership).
| Name | Role | Group |
|---|---|---|
Ravi Amunugama | Co-Founder | Leadership |
Richard Jones | Co-Founder | Leadership |
Michael Ford | Co-Founder | Leadership |
David Allen | Co-Founder | Leadership |
Complete people profiles for MS Bioworks
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Similar companies to MS Bioworks
MS Bioworks has 3 listed similar companies in our database, 3 of them funded. They include Nautilus Biotechnology, ProteinSimple and Somalogic.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nautilus.bio | 2016 | Seattle, United States | $103.26M | 134 | A proteomics platform is developed for analyzing the human proteome. | |
| proteinsimple.com | 2004 | San Jose, United States | $114.29M | 157 | Provider tools to help researchers with protein analysis | |
| somalogic.com | 1999 | Boulder, United States | $663.99M | 319 | Protein-based assays are developed for life science research. |
Detailed similar companies of MS Bioworks
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MS Bioworks
The website of MS Bioworks (msbioworks.com) receives about 10.4K visits a month.
- Monthly visits10.4K
▲ 228.9% vs previous month
Websites whose visitors overlap most with MS Bioworks. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| arborbiosci.com | 24% | 14.3K | #1,335,717 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as MS Bioworks (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MS Bioworks
MS Bioworks was founded in 2010.
MS Bioworks is headquartered in Detroit, United States. It is registered at Detroit, Michigan, United States.
MS Bioworks delivers advanced proteomics services using mass spectrometry to analyze proteins and their modifications. Based in Ann Arbor, Michigan, USA, the company serves over 2,000 global customers with offerings like reactive cysteine profiling, immunopeptidomics, and quantitative proteomics. They handle projects from routine protein identification to custom assays, ensuring high-quality results for research in healthcare and biotechnology.
MS Bioworks's top competitors include Somalogic, Nautilus Biotechnology and ProteinSimple.
MS Bioworks offers Reactive Cysteine Profiling, MHC Immunopeptidomics, High Resolution Spatial Proteomics, Quantitative Proteomics Services, and Post-Translational Modification Analysis.